Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs ALK✓SelectedUSD · ALKMRNA vs ALK performance historyLatest closeAs of+1.29%11/19
Stock and ETF performance explorer

MRNA vs ALK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+152.4%
ALK return
-2.2%
Excess return
+154.7%
Maximum drawdown
-86.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioALKExcessAlpha
1D+1.3%-2.2%+3.5%+1.8%
7D-13.8%-8.2%-5.6%-12.1%
30D-17.7%+4.3%-22.0%-18.4%
3M+14.3%-13.1%+27.4%+18.4%
6M+336.0%-1.0%+337.0%+328.8%
YTD+575.9%-28.7%+604.7%+613.9%
1Y+724.4%-7.2%+731.6%+708.4%
All+152.4%-2.2%+154.7%+131.9%

Cumulative growth

Daily Returns

Daily percentage return beside ALK.

Daily Out/Under-Performance

Portfolio return minus ALK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × ALK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded ALK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling